United States Hemophilia Market and Competitive Landscape 2014-2018 & Forecast to 2023 - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Oct 10, 2018--The “US Hemophilia Market and Competitive Landscape - 2018” report has been added to ResearchAndMarkets.com’s offering.
US Hemophilia Market and Competitive Landscape - 2018, provides comprehensive insights into Hemophilia pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Hemophilia market size and drug sales. This research also provides insights into Hemophilia epidemiology and late stage pipeline.
The research is classified into following sections - Hemophilia overview with definitions, symptoms, etiology, diagnosis, treatment options; Hemophilia pipeline insights covering late stage clinical trials pipeline; Hemophilia prevalence trends by countries; Hemophilia market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries.
Research Scope:Hemophilia pipeline: Find out the drugs in clinical trials for Hemophilia by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by company Hemophilia epidemiology: Find out the prevalence of Hemophilia in US; prevalence forecast to 2023 Hemophilia products: Identify key products marketed and prescribed for Hemophilia by brand name, by molecule, by company, by branded / generic, in US Hemophilia market size: Find out the market size for Hemophilia drugs in US; Find out how the market advanced from 2014 Hemophilia drug sales: Find out the sales of Hemophilia drugs in US Hemophilia drugs sales forecast: Sales forecast for Hemophilia drugs to 2023 in US Hemophilia market share analysis: Find out the market shares of Hemophilia drugs and outlook in US
For more information about this report visit https://www.researchandmarkets.com/research/xfv952/united_states?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20181010005776/en/
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Hematological Drugs
KEYWORD: UNITED STATES NORTH AMERICA
INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 10/10/2018 12:24 PM/DISC: 10/10/2018 12:24 PM